Windlas Biotech Limited (BOM:543329)
India
· Delayed Price · Currency is INR 915.65
-2.80 (-0.30%)
At close: Jun 6, 2025
Windlas Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| Net Income | 609.94 | 581.87 | 426.26 | 380.89 | 158.32 | Upgrade
|
| Depreciation & Amortization | 279.85 | 131.98 | 121.66 | 119.26 | 124.66 | Upgrade
|
| Other Amortization | - | 2.46 | 1.98 | 2.21 | 4.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.09 | -0.06 | -8.76 | -0.1 | -0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.08 | - | 286.64 | Upgrade
|
| Loss (Gain) From Sale of Investments | -150.79 | -108.21 | -47.82 | -17.24 | -62.22 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 1.73 | Upgrade
|
| Stock-Based Compensation | 24.6 | 20.67 | 10.08 | 18.13 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 1 | 27.49 | 22.75 | 3.48 | 10.62 | Upgrade
|
| Other Operating Activities | 8.28 | -6.13 | 20.22 | -39.65 | -9.72 | Upgrade
|
| Change in Accounts Receivable | -308.03 | -198.35 | -83.63 | -316.73 | -148.35 | Upgrade
|
| Change in Inventory | -191.95 | 125.49 | -160.28 | -172.49 | 100.7 | Upgrade
|
| Change in Accounts Payable | 357.26 | 437.68 | 245.12 | 233.04 | -460.39 | Upgrade
|
| Change in Other Net Operating Assets | 51.8 | 74.71 | 61.99 | -119.5 | 107.65 | Upgrade
|
| Operating Cash Flow | 681.87 | 1,090 | 609.65 | 91.3 | 114.54 | Upgrade
|
| Operating Cash Flow Growth | -37.42% | 78.72% | 567.74% | -20.29% | -54.20% | Upgrade
|
| Capital Expenditures | -521.94 | -376.84 | -708.9 | -148.04 | -58.47 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.97 | 0.42 | 9.1 | 1.1 | 0.15 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -1,035 | Upgrade
|
| Investment in Securities | -236.94 | -561.67 | 513.2 | -1,424 | 874.72 | Upgrade
|
| Other Investing Activities | 16.27 | 17.41 | 45.5 | 25.62 | 16.62 | Upgrade
|
| Investing Cash Flow | -740.64 | -920.68 | -141.1 | -1,546 | -201.98 | Upgrade
|
| Short-Term Debt Issued | 270.08 | - | - | - | 84.6 | Upgrade
|
| Total Debt Issued | 270.08 | - | - | - | 84.6 | Upgrade
|
| Short-Term Debt Repaid | - | -2.26 | -53.42 | -248.07 | - | Upgrade
|
| Long-Term Debt Repaid | -145.44 | -16.33 | -16.52 | -9.05 | -50.45 | Upgrade
|
| Total Debt Repaid | -145.44 | -18.59 | -69.94 | -257.12 | -50.45 | Upgrade
|
| Net Debt Issued (Repaid) | 124.64 | -18.59 | -69.94 | -257.12 | 34.15 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,650 | - | Upgrade
|
| Repurchase of Common Stock | - | -40.23 | -271.93 | - | - | Upgrade
|
| Common Dividends Paid | -114.95 | -83.01 | -76.28 | - | - | Upgrade
|
| Other Financing Activities | 0.44 | -11.07 | -19.24 | -92 | -26.39 | Upgrade
|
| Financing Cash Flow | 10.13 | -152.9 | -437.39 | 1,301 | 7.76 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 58.2 | Upgrade
|
| Net Cash Flow | -48.64 | 16.02 | 31.16 | -153.6 | -21.48 | Upgrade
|
| Free Cash Flow | 159.93 | 712.76 | -99.25 | -56.74 | 56.07 | Upgrade
|
| Free Cash Flow Growth | -77.56% | - | - | - | -42.17% | Upgrade
|
| Free Cash Flow Margin | 2.10% | 11.30% | -1.93% | -1.22% | 1.31% | Upgrade
|
| Free Cash Flow Per Share | 7.57 | 34.15 | -4.59 | -2.77 | 3.08 | Upgrade
|
| Cash Interest Paid | 43.82 | 11.07 | 7.87 | 14.15 | 13.65 | Upgrade
|
| Cash Income Tax Paid | 208.84 | 186.48 | 97.16 | 88.8 | 65.32 | Upgrade
|
| Levered Free Cash Flow | 68.99 | 629.88 | -124.53 | -167.52 | -154.28 | Upgrade
|
| Unlevered Free Cash Flow | 96.37 | 636.79 | -119.6 | -158.67 | -146.21 | Upgrade
|
| Change in Net Working Capital | 99.4 | -453.97 | -156.39 | 401.95 | 488.73 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.